Cargando…

Chagas Disease Cardiomyopathy: Immunopathology and Genetics

Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and affects ca. 10 million people worldwide. About 30% of Chagas disease patients develop chronic Chagas disease cardiomyopathy (CCC), a particularly lethal inflammatory cardiomyopathy that occurs decades after th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunha-Neto, Edecio, Chevillard, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152981/ https://www.ncbi.nlm.nih.gov/pubmed/25210230 http://dx.doi.org/10.1155/2014/683230

Ejemplares similares

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy
por: Chevillard, Christophe, et al.
Publicado: (2018)

Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways
por: Frade, Amanda Farage, et al.
Publicado: (2013)

Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
por: Teixeira, Priscila Camillo, et al.
Publicado: (2021)

ChagasDB: 80 years of publicly available data on the molecular host response to Trypanosoma cruzi infection in a single database
por: Brochet, Pauline, et al.
Publicado: (2023)

Immunopathological Mechanisms Underlying Cardiac Damage in Chagas Disease
por: De Alba-Alvarado, Mariana Citlalli, et al.
Publicado: (2023)

Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy
por: Frade-Barros, Amanda Farage, et al.
Publicado: (2020)

Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs
por: Baron, Monique Andrade, et al.
Publicado: (2022)

Corrigendum: Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy
por: Farage Frade-Barros, Amanda, et al.
Publicado: (2020)

Mitochondria as a Cellular Hub in Infection and Inflammation
por: Andrieux, Pauline, et al.
Publicado: (2021)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
por: de Souza Pimentel, Walace, et al.
Publicado: (2012)

Whole-Genome Cardiac DNA Methylation Fingerprint and Gene Expression Analysis Provide New Insights in the Pathogenesis of Chronic Chagas Disease Cardiomyopathy
por: Laugier, Laurie, et al.
Publicado: (2017)

miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy
por: Laugier, Laurie, et al.
Publicado: (2020)

Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects
por: Deng, Xutao, et al.
Publicado: (2013)

Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical forms
por: Brochet, Pauline, et al.
Publicado: (2022)

Selective Decrease of Components of the Creatine Kinase System and ATP Synthase Complex in Chronic Chagas Disease Cardiomyopathy
por: Teixeira, Priscila Camillo, et al.
Publicado: (2011)

Immunology and Infection by Protozoan Parasites
por: Cunha-Neto, Edecio, et al.
Publicado: (2015)

Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease
por: Ouarhache, Maryem, et al.
Publicado: (2021)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Editorial: Mitochondria at the Crossroads of Immunity and Inflammatory Tissue Damage
por: Nunes, João Paulo Silva, et al.
Publicado: (2021)

Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy
por: Romano, Minna M. D., et al.
Publicado: (2017)

Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease
por: Ayo, Christiane Maria, et al.
Publicado: (2015)

Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy
por: de Oliveira, Luciano Fonseca Lemos, et al.
Publicado: (2016)

Genetically Determined MBL Deficiency Is Associated with Protection against Chronic Cardiomyopathy in Chagas Disease
por: Luz, Paola Rosa, et al.
Publicado: (2016)

Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy
por: Brochet, Pauline, et al.
Publicado: (2022)

Co-Exposure of Cardiomyocytes to IFN-γ and TNF-α Induces Mitochondrial Dysfunction and Nitro-Oxidative Stress: Implications for the Pathogenesis of Chronic Chagas Disease Cardiomyopathy
por: Nunes, João Paulo Silva, et al.
Publicado: (2021)

Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile
por: Cardoso, Clareci Silva, et al.
Publicado: (2016)

Myocardial Gene Expression of T-bet, GATA-3, Ror-γt, FoxP3, and Hallmark Cytokines in Chronic Chagas Disease Cardiomyopathy: An Essentially Unopposed T(H)1-Type Response
por: Nogueira, Luciana Gabriel, et al.
Publicado: (2014)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10
por: Nogueira, Luciana Gabriel, et al.
Publicado: (2012)

Chagas Cardiomyopathy in the Context of the Chronic Disease Transition
por: Hidron, Alicia I., et al.
Publicado: (2010)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Clinical Presentations of Chagas Cardiomyopathy
por: Shehadeh, Malik, et al.
Publicado: (2020)

Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display
por: Rodriguez Carnero, Luis Antonio, et al.
Publicado: (2023)

Evidence for T Cell Help in the IgG Response against Tandemly Repetitive Trypanosoma cruzi B13 Protein in Chronic Chagas Disease Patients
por: Duranti, Marcia, et al.
Publicado: (2012)

COPD immunopathology
por: Caramori, Gaetano, et al.
Publicado: (2016)

Chagas Disease Megaesophagus Patients Carrying Variant MRPS18B P260A Display Nitro-Oxidative Stress and Mitochondrial Dysfunction in Response to IFN-γ Stimulus
por: Silva, Karla Deysiree Alcântara, et al.
Publicado: (2022)

The immunopathology of canine vector-borne diseases
por: Day, Michael J
Publicado: (2011)

Role of Semaphorins in Immunopathologies and Rheumatic Diseases
por: Garcia, Samuel
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gpajmfk1shai41dbctcnuulq2q